Transforming growth factor βs and wound healing

International Journal of Biochemistry and Cell Biology

Volumn 29, Issue 1, 1997, Pages 63-78

  O'Kane, Sharon ^a   Ferguson, Mark W J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chronic wounds; Fibrosis; Scarring; TGF s; Wound healing

Indexed keywords

ACTIVIN; BONE MORPHOGENETIC PROTEIN; CYTOKINE; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

FIBROSIS; HISTOCHEMISTRY; HUMAN; NONHUMAN; PROTEIN FAMILY; REVIEW; SCAR FORMATION; SIGNAL TRANSDUCTION; WOUND HEALING;

ANIMALS; ANTIBODIES; CICATRIX; FIBROSIS; HUMANS; MODELS, BIOLOGICAL; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

MAMMALIA;

EID: 0031016797     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(96)00120-3     Document Type: Review

References (131)

1. Alexandrow M. G. and Moses H. L. (1995) Transforming growth-factor-β and cell-cycle regulation. Cancer Res. 55, 1452-1457.
2. Ashcroft G. S., Horan M. A. and Ferguson M. W. J. (1995) The effects of ageing on cutaneous wound healing in mammals. J. Anat. 187, 1-26.
3. Barcellos-Hoff M. H. (1995) Redox mediated latent TGF-β activation. Faseb J. 9, A125.
4. Barcellos-Hoff M. H., Derynck R., Tsang M. L.-S. and Weatherbee J. A. (1994) Transforming growth factor β activation in irradiated murine mammary gland. J. Clin. Invest. 93, 892-899.
5. Beck L. S., DeGuzman L., Lee W. P., Xu Y., Siegel M. W. and Amento E. P. (1993) One systemic administration of transforming growth factor-β reverses age-or glucocorticoid-impaired wound healing. J. Clin. Invest. 92, 2841-2849.
6. Bernasconi P., Torchiana E., Confalonieri P., Brugnoni R., Barresi R., Mora M., Cornelio F., Morandi L. and Mantegazza R. (1995) Expression of transforming growth factor-β1 in dystrophic patient muscles correlates with fibrosis. J. Clin. Invest. 96, 1137-1144.
7. Bodo M., Venti G., Baroni T., Belluci C., Giammarioli M., Donti E., Paludetti G., Stabellini G. and Carinci P. (1995) Phenotype of in vitro human otosclerotic cells and its modulation by TGF-β. Cell. Mol. Biol. 41, 1039-1049.
8. Bollineni J. S. and Reddi A. S. (1993) Transforming growth factor-β1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 42, 1673-1677.
9. Border W. A., Okuda S., Languino L. R., Sporn M. B. and Rouslahti E. (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1. Nature 346, 371-374.
10. Border W. A. and Noble N. A. (1994) Transforming growth factor β in tissue fibrosis. N. Engl. J. Med. 331, 1286-1292.
11. Bottinger E. P., Factor V. M., Tsang M. L.-S., Weatherbee J. A., Kopp J. B., Qian S. W., Wakefield L. M., Roberts A. B., Thorgeirsson S. S. and Sporn M. B. (1996) The recombinant proregion of transforming growth factor β1 (latency-associated peptide) inhibits active transforming growth factor β1 in transgenic mice. Proc. Natl Acad. Sci. U.S.A. 93, 5877-5882.
12. Broekelmann T. J., Limper A. H., Colby T. V. and McDonald J. A. (1991) Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl Acad. Sci. U.S.A. 88, 6642-6646.
13. Brown R. L., Ormsby I., Doetschmann T. C. and Greenhalgh D. G. (1995) Wound healing in the transforming growth factor β-deficient mouse. Wound Rep. Reg. 3, 25-36.
14. Cheifetz S., Bassols A., Stanley K., Ohta M., Greenberger J. and Massagué J. (1988) Heterodimeric transforming growth factor β; biological properties and interaction with three types of cell surface receptors. J. biol. Chem. 263, 10783-10789.
15. Coghlan A, (1996) Do it all protein helps kidney repair. New Scientist 150, 2031, 25.
16. Connor T. B., Roberts A. B., Sporn M. B., Danielpour D., Dart L. L., Michels R. G., de Bustros S., Enger C., Kato H., Lansing M., Hiyashi H. and Glaser B. M. (1989) Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J. Clin. Invest. 83, 1661-1666.
17. Corrin B., Butcher D., McAnulty R. J., du Bois R. M., Black C. M., Laurent G. J. and Harrison N. K. (1994) Immunohistochemical localization of transforming growth factor-β1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology 24, 145-150.
18. Cox D. A., Kunz S., Cerletti N., McMaster G. K. and Burk R. R. (1992) Wound healing in aged animals: effect of locally applied TGF-β2 in different model systems. In Angiogenesis - Key Principles (Eds Steiner R., Weisz P. B. and Langer R.), pp. 287-295. Birkhauser. Basel.
19. Danielpour D. and Sporn M. B. (1990) Differential inhibition of transforming growth factor β1 and β2 activity by α2-macroglobulin. J. biol. Chem. 265, 6973-6977.
20. Denis M. (1994) Neutralization of transforming growth factor β1 in a mouse model of immune-induced lung fibrosis. Immunology 82, 584-590.
21. Dennis P. A. and Rifkin D. B. (1991) Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate insulin-like growth-factor type-II receptor. Proc. Natl Acad. Sci. U.S.A. 88, 580-584.
22. Derynck R. (1994) TGF-β-receptor-mediated signalling. Trends Biochem. Sci. 19, 548-553.
23. DuBois C. M., Laprise M. H., Blanchette F., Gentry L. E. and Leduc R. (1995) Processing of transforming growth-factor-β-1 precursor by human furin convertase. J. biol. Chem. 270, 10618-10624.
24. Fajardo L. F., Prionas S. D., Kwan H. H., Kowalski J. and Allison A. C. (1996) Transforming growth factor β1 induces angiogenesis in vivo with a threshold pattern. Lab. Invest. 74, 600-608.
25. Feng X.-H., Filvaroff E. H. and Derynck R. (1995) Transforming growth factor β (TGFβ) -induced downregulation of cyclin-A expression requires a functional TGFβ receptor complex - characterization of chimeric and truncated type I and type II receptors. J. biol. Chem. 270, 24237-24245.
26. Ferguson M. W. J., Whitby D, J., Shah M., Armstrong J., Siebert J. W. and Longaker M. T. (1996) Scar formation: the spectral nature of fetal and adult wound repair. Plast. Reconstr. Surg. 97, 854-860.
27. Frank S., Madlener M. and Werner S. (1996) Transforming growth factors β1, β2 and β3 and their receptors are differentially regulated during normal and impaired wound healing. J. biol. Chem. 271, 10188-10193.
28. Giri S. N., Hyde D. M. and Hollinger M. A. (1993) Effect of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice. Thorax 48, 959-966.
29. Glaser B. M., Michels R. G., Kuppermann B. D., Sjaarda R. N. and Pena R. A. (1992) Transforming growth factor-beta 2 for the treatment of full thickness macular holes. A prospective randomized study. Ophthalmology 99, 1162-1172.
30. Graff J. M., Bansal A. and Melton D. A. (1996) Xenopus Mad proteins transduce distinct subsets of signals for the TGFβ superfamily. Cell 85, 479-487.
31. Grainger D. J. and Metcalfe J. C. (1996) Tamoxifen: teaching an old dog new tricks? Nature Med. 2, 381-385.
32. Grainger D. J., Kemp B. R., Metcalfe J. C., Liu A. C., Lawn R. M., Williams N. R., Grace A. A., Schofield P. M. and Chauhan A. (1995a) The serum concentration of active transforming growth-factor-beta is severely depressed in advanced atherosclerosis. Nature Med. 1, 74-79.
33. Grainger D. J., Wakefield L., Bethell H. W., Farndale R. W. and Metcalfe J. C. (1995b) Release and activation of platelet latent TGFβ in blood clots during dissolution with plasmin. Nature Med. 1, 932-937.
34. Hahn S. A., Schutte M., Shamsul Hoque A. T. M., Moskaluk C. A., da Costa L. T., Rozenblum E., Weinstein C. L., Fischer A., Yeo C. J., Hruban R. H. and Kern S. E. (1996) A candidate tumour suppressor gene at human chromosome 18q21.1. Science 271, 350-353.
35. Harpel J. G., Metz C. N., Kojima S. and Rifkin D. B. (1992) Control of transforming growth factor beta activity: latency vs. activation. Prog. Growth Factor Res. 4, 321-335.
36. Herrick S. E., Sloan P., McGurk M., Freak L., McCollum C. N. and Ferguson M. W. J. (1992) Sequential-changes in histologic pattern and extracellular-matrix deposition during the healing of chronic venous ulcers. Am. J. Pathol. 141, 1085-1095.
37. Higley H. R., Ksander G. A., Gerhardt C. O. and Falanga V. (1995) Extravasation of macromolecules and possible trapping of transforming growth factor-β in venous ulceration. Br. J. Dermatol. 132, 79-85.
38. Hildebrand A., Romans M., Rasmussen L. M., Heinegard D., Twardzik D., Border W. A. and Rouslahti E. (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J. 303, 527-534.
39. Hoodless P. A., Haerry T., Abdollah S., Stapleton M., O'Connor M. B., Attisano L. and Wrana J. L. (1996) MADR1, a MAD-related protein that functions in BMP2 signalling pathways. Cell 85, 489-500.
40. Hoyt D. G. and Lazo J. S. (1988) Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-β precede bleomycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 246, 765-771.
41. Hubner G., Hu Q., Smola H. and Werner S. (1996) Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev. Biol. 173, 490-498.
42. Isaka Y., Brees D. K., Ikegaya K., Kaneda Y., Imai E., Noble N. A. and Border W. A. (1996) Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nature Med. 2, 418-423.
43. Jeng M. H., TenDijke P., Iwata K. K. and Jordan V. C. (1993) Regulation of the levels of 3 transforming growth factor beta messenger RNAs by estrogen and their effects on the proliferation of human breast cancer cells. Mol. Cell. Endocrinol. 97, 115-123.
44. Johnson D. W., Berg J. N., Baldwin M. A., Gallione C. J., Marondel I., Yoon S. J., Stenzel T. T., Speer M., Pericakvance M. A., Diamond A., Guttrnacher A. E., Jackson C. E., Attisano L., Kucherlapati R., Porteous M. E. M. and Marchuk D. A. (1996) Mutations in the activin receptor-like kinase-1 gene in hereditary hemorrhagic telangiectasia type-2. Nature Genet. 13, 189-195.
45. Kagami S., Border W. A., Miller D. E. and Noble N. A. (1994) Angiotensin-II stimulates extracellular-matrix protein-synthesis through induction of transforming growth-factor beta expression in rat glomerular mesangial cells. J. Clin. Invest. 93, 2431-2437.
46. Kane C. J., Hebda P. A., Mansbridge J. N. and Hanawalt P. C. (1991) Direct evidence for spatial and temporal regulation of transforming growth factor β1 expression during cutaneous wound healing. J. Cell Physiol. 148, 157-173.
47. Khalil N., O'Connor R. N., Unruh H. W., Warren P. W., Flanders K. C., Kemp A., Bereznay O. H. and Greenberg A. H. (1991) Increased production and immunohistochemical localization of transforming growth factor-β in idiopathic pulmonary fibrosis. Am. J. Respir. Cell. Mol. Biol. 5, 155-162.
48. Khalil N., O'Connor R. N., Flanders K. C. and Unruh H. (1996) TGF-β1 but not TGF-β2 or TGF-β3 is differentially present in epithelial cells of advanced pulmonary fibrosis-an immunohistochemical study. Am. J. Resp. Cell. Mol. Biol. 14, 131-138.
49. Kingsley D. M. (1994a) The TGF-β superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev. 8, 133-146.
50. Kingsley D. M. (1994b) What do BMPs do in mammals? Clues form the short-ear mutation. Trends Genet. 10, 16-21.
51. Kojima S. and Rifkin D. B. (1993) Mechanism of retinoid-induced activation of latent transforming growth factor-beta in bovine endothelial cells. J. Cell Physiol. 155, 323-332.
52. Krummel T. M., Michna B. A., Thomas B. L., Sporn M. B., Nelson J. M., Salzberg A. M., Cohen I. K. and Diegelmann R. F. (1988) Transforming growth factor beta (TGF-β) induces fibrosis in a fetal wound model. J. Pediat. Surg. 23, 647-652.
53. Kulkarni A. B., Huh C. G., Becker D., Geiser A., Lyght M., Flanders K. C., Roberts A. B., Sporn M. B., Ward J. M. and Karlsson S. (1993) Transforming growth factor-β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl Acad. Sci. U.S.A. 90, 770-774.
54. Levine J. H., Moses H. L., Gold L. I. and Nanney L. B. (1993) Spatial and temporal patterns of immunoreactive transforming growth factor β1, β2 and β3 during excisional wound repair. Am. J. Pathol. 143, 368-380.
55. Liu F., Hata A., Baker J. C., Doody J., Carcamo J., Harland R. M. and Massagué J. (1996) A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623.
56. Logan A., Berry M., Gonzalez A. M., Frautschy S. A., Sporn M. B. and Baird M. W. J. (1994) Effects of transforming growth factor-β1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 6, 355-363.
57. Ludwicka A., Ohba T., Trojanowska M., Yamakage A., Strange C., Smith E. A., Leroy E. C., Sutherland S. and Silver R. M. (1995) Elevated levels of platelet derived growth factor and transforming growth factor β1 in bronchoalveolar lavage fluid from patients with scleroderma. J. Rheum. 22, 1876-1883.
58. Luo G., Hofmann C., Bronckers A. L. J. J., Sohocki M., Bradley A. and Karsenty G. (1995) BMP-7 is an inducer of nephrogenesis and is also required for eye development and skeletal patterning. Genes Dev. 9, 2808-2820.
59. Lyons K. M., Jones C. M. and Hogan B. L. M. (1991) The DVR gene family in embryonic development. Trends Genet. 7, 408-412.
60. Lyons R. M., Gentry L. E., Purchio A. F. and Moses H. L. (1990) Mechanism of activation of latent recombinant transforming growth factor-β1 by plasmin. J. Cell Biol. 110, 1361-1367.
61. Mariani T. J., Roby J. D., Mecham R. P., Parks W. C., Crouch E. and Pierce R. A. (1996) Localization of type-I procollagen gene expression in silica-induced granulomatous lung disease and implication of transforming growth factor β as a mediator of fibrosis. Am. J. Pathol. 148, 151-164.
62. Martyre M. C. (1995) TGF-β and megakaryocytes in the pathogenesis of myelofibrosis in myeloproliferative disorders. Leukemia Lymphoma 20, 39.
63. Massagué J. (1990) The transforming growth factor-beta family. Annu. Rev. Cell. Biol. 6, 597-641.
64. Massagué J., Attisano L. and Wrana J. L. (1994) The TGFβ family and its composite receptors. Trends Cell. Biol. 4, 172-178.
65. Massagué J. (1996) TGFβ signalling: receptors, transducers and Mad proteins. Cell 85, 947-950.
66. Mathews L. S. (1994) Activin receptors and cellular signaling by the receptor serine kinase family. Endocr. Rev. 15, 310-325.
67. Matsuse T., Fukuchi Y., Eto Y., Matsui H., Hosoi T., Oka T., Ohga E., Nagase T. and Orimo H. (1995) Expression of immunoreactive and bioactive Activin-A protein in adult murine lung after bleomycin treatment. Am. J. Resp. Cell. Mol. Biol. 13, 17-24.
68. McAllister K. A., Grogg K. M., Johnson D. W., Gallione C. J., Baldwin M. A., Jackson C. E., Helmbold E. A., Markel D. S., McKinnon W. C., Murrell J., McCormick M. K., Pericavance M. A., Heutink P., Oostra B. A., Haitjema T., Westerman C. J. J., Porteous M. E., Guttmacher A. E., Letarte M. and Marchuk D. A. (1994) Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type-1. Nature Genet. 8, 345-351.
69. McAnulty R, J. and Laurent G. J. (1995) Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp. Nephrol. 3, 96-107.
70. McCallion R. L. and Ferguson M. W. J. (1996) Fetal wound healing and the development of antiscarring therapies for adult wound healing. In The Molecular and Cellular Biology of Wound Repair (Ed. Clark R. A. F.), pp. 561-600. Plenum Press, New York.
71. McGee G. S., Broadley K. N., Buckley A., Aquino A., Woodward S. C., Demetriou A. A. and Davidson J. M. (1989) Recombinant transforming growth factor beta accelerates incisional wound healing. Curr. Surg. 46, 103-106.
72. Meno C., Saijoh Y., Fujii H., Ikeda M., Yokoyama T., Yokoyama M., Toyoda Y. and Hamada H. (1996) Left-right asymmetric expression of the TGF-β-family member lefty in mouse embryos. Nature 381, 151-155.
73. Miyazono K., Olofsson A., Colosetti P. and Heldin C. H. (1991) A role of the latent TGF-β1 binding protein in the assembly and secretion of TGFβ1. EMBO J. 10, 1091-1101.
74. Mustoe T. A., Pierce G. F., Thomason A., Gramates P., Sporn M. B. and Deuel T. F. (1987) Accelerated healing of incisional wounds in rats induced by transforming growth factor-β. Science 237, 1333-1336.
75. Nagy P., Schaff Z. and Lapis K. (1991) Immunohistochemical detection of transforming growth factor β1 in fibrotic liver diseases. Hepalology 14, 269-273.
76. Nath R. K., LaRegina M., Markham H., Ksander G. A. and Weeks P. M. (1994) The expression of transforming growth factor type beta in fetal and adult rabbit skin wounds. J. Pediat. Surg. 29, 416-421.
77. Nikol S., Isner J. M., Pickering J. G., Kearney M., Leclerc G. and Weir L. (1992) Expression of transforming growth factor β1 is increased in human vascular restenosis lesions. J. Clin. Invest. 90, 1582-1592.
78. O'Grady P., Kuo M.-D., Baldassare J. J., Huang S. S. and Huang J. S. (1991) Purification of a new type high molecular weight receptor (Type V Receptor) of transforming growth factor β (TGF-β) from bovine liver. J. biol. Chem. 266, 8583-8589.
79. Ogawa Y., Schmidt D. K., Dasch J. R., Chang R.-J. and Glaser C. B. (1992) Purification and characterisation of transforming growth factor-β2.3 and -β1.2 heterodimers from bovine bone. J. biol. Chem. 267, 2325-2328.
80. Okuda S., Languino L. R., Rouslahti E. and Border W. A. (1990) Elevated expression of transforming growth factor-β and proteoglycan production in experimental glomerulonephritis: possible role in expansion of the mesangial extracellular matrix. J. Clin. Invest. 86, 453-462.
81. Peltonen J., Hsiao L. L., Jaakkola S., Sollberg S., Aumailley M., Timpl R., Chu M. L. and Uitto J. (1991) Activation of collagen gene expression in keloids: co-localization of type I and type VI collagen and transforming growth factor β1 mRNA. J. Invest. Dermatol. 97, 240-248.
82. Pierce G. F., Mustoe T. A., Lingelbach J., Masakowski V. R., Gramates P. and Deuel T. F. (1989) Transforming growth factor β reverses the glucocorticoid-induced wound healing deficit in rats: possible regulation in macrophages by platelet-derived growth factor. Proc. Natl Acad. Sci. U.S.A. 86, 2229-2233.
83. Proetzel G., Pawlowski S. A., Wiles M. V., Yin M. Y., Boivin G. P., Howles P. N., Ding J. X., Ferguson M. W. J. and Doetschman T. (1995) Transforming growth factor-β3 is required for secondary palate fusion. Nature Genet. 11, 409-414.
84. Purchio A. F., Cooper J. A., Brunner A. M., Lioubin M. N., Gentry L. E., Kovacina K. S., Roth R. A. and Marquardt H. (1988) Identification of mannose 6-phosphate in 2 asparagine-linked sugar chains of recombinant transforming growth factor-β-1 precursor. J. biol. Chem. 263, 14211-14215.
85. Quaglino D., Nanney L. B., Ditesheim J. A. and Davidson J. M. (1991) Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: incisional wound model. J. Invest. Dermatol. 97, 34-42.
86. Quaglino D., Nanney L. B., Kennedy R. and Davidson J. M. (1990) Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: excisional wound model. Lab. Invest. 63, 307-319.
87. Roberts A. B. (1996) Transforming growth factor β: activity and efficacy in animal models of wound healing. Wound Rep. Reg. 3, 408-418.
88. Roberts A. B. and Sporn M. B. (1990) The transforming growth factors-β. In Handbook of Experimental Pharmacology; Peptide Growth Factors and their Receptors. (Eds M. B. Sporn and A. B. Roberts). Vol. 95, pp. 419-472. Springer-Verlag, New York.
89. Roberts A. B., Sporn M. B., Assoian R. K., Smith J. M., Roche N. S., Wakefield L. M., Heine U. I., Liotta L. A., Falanga V., Kehrl J. H. and Fauci A. S. (1986) Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl Acad. Sci. U.S.A. 83, 4167-4171.
90. Robson M. C., Phillip L. G., Cooper D. M., LyIe W. G., Robson L. E., Odom L., Hill D. P., Hanham A. F. and Ksander G. A. (1995) Safety and effect of transforming growth factor-β2 for treatment of venous stasis ulcers. Wound Rep. Reg. 3, 157-167.
91. Rosenzweig B. L., Imamura T., Okadome T., Cox G. N., Yamashita H., ten Dijke P., Heldin C. H. and Miyazono K. (1995) Cloning and characterisation of a human Type II receptor for bone morphogenetic proteins. Proc. Natl Acad. Sci. U.S.A. 92, 7632-7636.
92. Rudnicka L., Varga J., Christiane A. M., Iozzo R. V., Jimenez S. A. and Uitto J. (1994) Elevated expression of type-VII collagen in the skin of patients with systemic-sclerosis - regulation by transforming growth-factor-β. J. Clin. Invest. 93, 1709-1715.
93. Russell S. B., Trupin K. M., Rodriguez-Eaton S., Russell J. D. and Trupin J. S. (1988) Reduced growth factor requirement of keloid-derived fibroblasts may account for tumour growth. Proc. Natl Acad. Sci. U.S.A. 85, 587-591.
94. Saharinen J., Taipale J. and Keski-Oja J. (1996) Association of the small latent transforming growth factor-β with an eight cysteine repeat of its binding protein (LTBP-1). EMBO J. 15, 245-253.
95. Salomon G. D., Kasid A., Bernstein E., Buresh C., Director E. and Norton J. A. (1990) Gene expression in normal and doxorubicin-impaired wounds: importance of transforming growth factor beta. Surgery 108, 318-322.
96. Sanderson N., Factor V., Nagy P., Kopp J., Kondaiah P., Wakefield L., Roberts A. B., Sporn M. B. and Thorgeirsson S. S. (1995) Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc. Natl Acad. Sci. U.S.A. 92, 2572-2576.
97. Sankar S., Mahooti-Brooks N., Bensen L., McCarthy T. L., Centrella M. and Madri J. A. (1996) Modulation of transforming growth factor β levels on microvascular endothelial cells during in vitro angiogenesis. J. Clin. Invest. 97, 1436-1446.
98. Santana A., Saxena B., Noble N. A., Gold L. I. and Marshall B. C. (1995) Increased expression of transforming growth factor β isoforms (β1, β2, β3) in bleomycin-induced pulmonary fibrosis. Am. J. Resp. Cell. Mol. Biol. 13, 34-44.
99. Savage C., Das P., Finelli A., Townsend S., Sun C., Baird S. and Padgett R. (1996) The C elegam sma-2, sma-3 and sma-4 genes define a novel conserved family of TGF-β pathway components. Proc. Natl Acad. Sci. U.S.A. 93, 790-794.
100. Schmid P., Cox D., Bilbe G., McMaster G., Morrison C., Stahelin H., Luscher N. and Seiler W. (1993a) TGF-βs and TGF-β Type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J. Pathol. 171, 191-197.
101. Schmid P., Kunz S., Cerletti N., McMaster G. and Cox D. (1993b) Injury induced expression of TGF-β1 mRNA is enhanced by exogenously applied TGF-βs. Biochem. Biophys. Res. Commun. 194, 399-406.
102. Schultz-Cherry S. and Murphy-Ulrich J. E. (1993) Thrombospondin causes activation of latent transforming growth factor β secreted by endothelial cells by a novel mechanism. J. Cell. Biol. 122, 923-932.
103. Sekelsky J. J., Newfeld S. J., Raftery L. A., Chartoff E. H. and Gelbart W. M. (1995) Genetic characterisation and cloning of Mothers against dpp, a gene required for decapentaplegic function in Drosophila melanogaster. Genetics 139, 1347-1358.
104. Shah M., Foreman D. M. and Ferguson M. W. J. (1992) Control of scarring in adult wounds by neutralising antibody to transforming growth factor β. Lancet 339, 213-214.
105. Shah M., Foreman D. M. and Ferguson M. W. J. (1994) Neutralizing antibodies to TGFβ1,2 reduces cutaneous scarring in adult rodents. J. Cell Sci. 107, 1137-1157.
106. Shah M., Foreman D. M. and Ferguson M. W. J. (1995) Neutralization of TGFβ1 and TGFβ2 or exogenous addition of TGFβ3 to cutaneous wounds reduces scarring. J. Cell Sci. 108, 983-1002.
107. Shah M., Whitby D. J. and Ferguson M. W. J. (1996) Fetal wound healing and scarless surgery. In Recent Advances in Plastic Surgery (Eds Jackson I. T. and Sommerlad B. C.), pp. 1-12. Churchill Livingstone, Edinburgh.
108. Shibuya H., Yamaguchi K., Shirakabe K., Tonegawa A., Gotoh Y., Ueno N., Irie K., Nishida E. and Matsumoto K. (1996) TAB1: an activator of the TAK1 MAPKK in TGFβ signal transduction. Science 272, 1179-1182.
109. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N. and Doetschmann T. (1992) Targeted disruption of the mouse transforming growth factor β1 gene results in multifocal inflammatory disease. Nature 359, 693-699.
110. Snowden N., Coupes B., Herrick A., Illingworth K., Jayson M. I. V. and Brenchley P. E. C. (1994) Plasma TGFβ in systemic sclerosis: a cross-sectional study. Ann. Rheum. Dis. 53, 763-767.
111. Sporn M. B., Roberts A. B., Shull J. H., Smith J. M. and Ward J. M. (1983) Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science 219, 1329-1330.
112. Sporn M. B. and Roberts A. B. (1992) Transforming growth factor-beta: recent progress and new challenges. J. Cell. Biol. 119, 1017-1021.
113. Sutton G. L., Patmore A., Verma S., Joussen A. M. and Marshall J. (1996) Neutralizing antibody to TGF-β and mannose-6-phosphate modulate corneal wound healing following PRK. Invest. Ophthal. Visual. Sci. 37, 924.
114. Taipale J., Miyazono K., Heldin C.-H. and Keski-Oja J. (1994) Latent transforming growth factor β1 associates to fibroblast extracellular matrix via latent TGF-β binding protein. J. Cell. Biol. 124, 171-181.
115. Takiya S., Tagaya T., Takahashi K., Kawashima H., Kamiya M., Fukuzawa Y., Kobayashi S., Futaksu A., Katoh K. and Kakumu S. (1995) Role of transforming growth-factor beta-1 on hepatic regeneration and apoptosis in liver diseases. J. Clin. Pathol. 48, 1093-1097.
116. Tuan T. L., Zhu J. Y., Sun B., Nichter L. S., Nimni M. E. and Laug W. E. (1996) Elevated levels of plasminogen-activator inhibitor-1 may account for the altered fibrinolysis by keloid fibroblasts. J. Invest. Dermatol. 106, 1007-1011.
117. Vale W., Hsueh A., Rivier C., and Yu J. (1990) The inhibin/activin family of hormones and growth factors. In Peptide Growth Factors and their Receptors. Handbook of Experimental Pharmacology (Eds Sporn M. A. and Roberts A. B.), pp. 211-248. Springer-Verlag, Berlin.
118. Wakefield L. M., Smith D. M., Flanders K. C. and Sporn M. B. (1988) Latent transforming growth factor-β from human-platelets - a high molecular-weight complex containing precursor sequences. J. biol. Chem. 263, 7646-7654.
119. Webb D. J., Atkins T. L., Crookston K. P., Burmester J. K., Qian S. W. and Gonias S. L. (1994) Transforming growth factor β isoform 2-specific high affinity binding to native α2-macroglobulin. J. biol. Chem. 269, 30402-30406.
120. Westergren-Thorsson G., Hernnas J., Sarnstrand B., Oldberg A., Heinegard D. and Malmstrom A. (1993) Altered expression of small proteoglycans, collagen, and transforming growth factor-β1 in developing bleomycin-induced pulmonary fibrosis in rats. J. Clin. Invest. 92, 632-637.
121. Whitby D. J. and Ferguson M. W. J. (1991a) The extracellular matrix in fetal and adult wound healing. Development 112, 651-668.
122. Whitby D. J. and Ferguson M. W. J. (1991b) Immunohistochemical localisation of growth factors in lip wounds of fetal, neonatal and adult mice. Dev. Biol. 147, 207-215.
123. Wieser R., Wrana J. L. and Massagué J. (1995) GS domain mutations that constitutively activate TbRI, the downstream signalling component in the TGFβ receptor complex. EMBO J. 14, 2199-2208.
124. Williams A. O. and Knapton A. D. (1996) Hepatic silicosis, cirrhosis, and liver-tumors in mice and hamsters - studies of transforming growth-factor-β expression. Hepatology 23, 1268-1275.
125. Wozney J. M. (1992) The bone morphogenetic protein family and osteogenesis. Mol. Reprod. Dev. 32, 160-167.
126. Wrana J. L., Attisano L., Wieser R., Ventura F. and Massagué J. (1994) Mechanism of activation of the TGF-β receptor. Nature 370, 341-347.
127. Yamaguchi K., Shirakabe K., Shibuya H., Irie K., Oishi I., Ueno N., Taniguchi T., Nishida E. and Matsumoto K. (1995) Identification of a member of the MAPKK family as a potential mediator of TGF-β signal transduction. Science 270, 2008-2011.
128. Yamamoto T., Nakamura T., Noble N. A., Rouslahti E. and Border W. A. (1993) Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc. Natl Acad. Sci. U.S.A. 90, 1814-1818.
129. Yamamoto T., Noble N. A., Miller D. E. and Border W. A. (1994) Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int. 45, 916-927.
130. Yin W., Smiley E., Germiller J., Mecham R. P., Florer J. B., Wenstrup R. J. and Bonadio J. (1995) Isolation of a novel latent transforming growth factor-β binding protein gene (LTBP-3). J. biol. Chem. 270, 10147-10160.
131. Ziyadeh F. N., Sharma K., Ericksen M. and Wolf G. (1994) Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor β. J. Clin. Invest. 93, 536-542.